Gastric Cancer Chemoprevention
| Autor: | Victoria P Y Tan, Benjamin C.Y. Wong |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Oncology
medicine.medical_specialty Cancer chemoprevention Population Gastroenterology law.invention Gastric adenocarcinoma chemistry.chemical_compound Pharmacotherapy Randomized controlled trial law Internal medicine Medicine education Aspirin education.field_of_study Nonsteroidal biology business.industry digestive oral and skin physiology Helicobacter pylori biology.organism_classification digestive system diseases chemistry business medicine.drug |
| Zdroj: | Gastroenterology Clinics of North America. 42:299-316 |
| ISSN: | 0889-8553 |
| DOI: | 10.1016/j.gtc.2013.02.001 |
| Popis: | Chemoprevention may form the cornerstone in the management of gastric adenocarcinoma of the future. Helicobacter pylori eradication and aspirin and/or nonsteroidal anti-inflammatory drug therapy have emerged as front-runner chemotherapeutic agents due to the putative pathogenic mechanisms that they address. Before a population-based chemopreventive strategy can be recommended on a large scale, randomized controlled trials with follow-up of more than 10 years of these 2 agents in populations at high gastric adenocarcinoma risk is urgently awaited. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|